The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse.

Yawen Wang,Jiadai Xu,Bei Xu,Panpan Li,Yang Yang, Wenjing Wang,Tianhong Xu,Aziguli Maihemaiti,Tianwei Lan,Pu Wang,Liang Ren,Chi Zhou,Xianmuseye Aihemaiti,Peng Liu

Cancer（2023）

引用 5|浏览15

暂无评分

摘要

In the setting of novel therapy, 1q gain/amp still acts as an independent adverse prognostic factor. Patients with 1q gain/amp achieved VGPR rapidly but had inferior survival.

查看译文

关键词

autologous stem cell transplantation,chromosome 1q gain/amp,minimal residual disease,multiple myeloma,response kinetics

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要